Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Akari Therapeutics PLC (AKTX) had Weighted-Average Shares Outstanding (Diluted) of 31.47M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.90M |
|
-- |
|
-- |
|
$3.12M |
|
$-3.12M |
|
$1.22M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-3.12M |
|
$-3.12M |
|
31.47M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
31.47M |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$3.30M |
|
-- |
|
$47.61M |
|
$50.91M |
|
$17.14M |
|
-- |
|
$8.17M |
|
$25.31M |
|
$25.61M |
|
$-22.00M |
|
$25.61M |
|
32.61M |
|
| Cash Flow Statement Financials | |
$-5.41M |
|
-- |
|
$5.51M |
|
$2.66M |
|
$2.77M |
|
$0.11M |
|
$1.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.19 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.40% |
|
8.61% |
|
-3.72% |
|
-7.40% |
|
$0.79 |
|
$-0.17 |
|
$-0.17 |
|